Furthermore, at physiologically relevant concentrations, Hsp70 disaggregation activity may lead to an increase in the number of aggregates, potentially leading to a proliferation of species that can amplify synucleinopathy disease pathology. This evidence concerns the gene HSPA4 and synucleinopathy.